Chinese Medical E-ournals Database
Adv Search
中华妇幼临床医学杂志(电子版)

Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition) ›› 2024, Vol. 20 ›› Issue (02): 172 -178. doi: 10.3877/cma.j.issn.1673-5250.2024.02.007

Forum

Gut mycobiome and pediatric inflammatory bowel disease

Qing Liu1, Zhiling Wang1,†()   

  1. 1. Department of Pediatric Gastroenterology, Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu 610041, Sichuan Province, China
  • Received:2023-12-23 Revised:2024-03-16 Published:2024-04-01
  • Corresponding author: Zhiling Wang
  • Supported by:
    China International Medical Foundation Project(Z-2017-27-2001); Technology Project of Science and Technology Department of Sichuan Province(2022YFS0026)
HTML ( ) PDF ( )

Gut mycobiome (fungi) is a crucial component of the intestinal microecosystem homeostasis. The advancement of technology contributes greatly to new research in this field. More and more pediatric gastroenterology studies have focused on the relationship between intestinal fungi and IBD. Gut mycobiome-based interventions may provide a new strategy for the treatment of IBD. In this study, we intend to elaborate the latest research status of the composition changes gut mycobiome, its potential use as biomarkers and targets for the treatment of IBD, aiming to provide reference for clinical understanding of the relationship between intestinal fungi and IBD.

Key words: Fungi, gastrointestinal, Inflammatory bowel diseases, Colitis, ulcerative, Crohn disease, Molecular targeted therapy, Candida, Malassezia, Saccharomyces cerevisiae, Child
[1]
Rao C, Coyte KZ, Bainter W, et al. Multi-kingdom ecological drivers of microbiota assembly in preterm infants[J]. Nature, 2021, 591(7851): 633-638. DOI: 10.1038/s41586-021-03241-8.
[2]
向梅，商丽红，杜丽娜，等. 相关生化指标在儿童炎症性肠病诊断中的价值[J/OL]. 中华妇幼临床医学杂志(电子版), 2018, 14(4): 441-446. DOI: 10.3877/cma.j.issn.1673-5250.2018.04.011.
[3]
Richard ML, Sokol H. The gut mycobiota: insights into analysis, environmental interactions and role in gastrointestinal diseases[J]. Nat Rev Gastroenterol Hepatol, 2019, 16(6): 331-345. DOI: 10.1038/s41575-019-0121-2.
[4]
Fuller MK. Pediatric inflammatory bowel disease: special considerations[J]. Surg Clin North Am, 2019, 99(6): 1177-1183. DOI: 10.1016/j.suc.2019.08.008.
[5]
Jagt JZ, van Rheenen PF, Thoma SMA, et al. The top 10 research priorities for inflammatory bowel disease in children and young adults: results of a James Lind Alliance Priority Setting Partnership[J]. Lancet Gastroenterol Hepatol, 2023, 8(8): 690-691. DOI: 10.1016/S2468-1253(23)00140-1.
[6]
Zhang F, Aschenbrenner D, Yoo JY, et al. The gut mycobiome in health, disease, and clinical applications in association with the gut bacterial microbiome assembly[J]. Lancet Microbe, 2022, 3(12): e969-e983. DOI: 10.1016/S2666-5247(22)00203-8.
[7]
孙耀华，白辰光. 念珠菌与消化道肿瘤关系的相关研究进展[J]. 中国真菌学杂志，2021, 16(2): 137-140. DOI: 10.3969/j.issn.1673-3827.2021.02.015.
[8]
Sun Y, Zuo T, Cheung CP, et al. Population-level configurations of gut mycobiome across 6 ethnicities in urban and rural China[J]. Gastroenterology, 2021, 160(1): 272-286.e11. DOI: 10.1053/j.gastro.2020.09.014.
[9]
Schei K, Simpson MR, Avershina E, et al. Early gut fungal and bacterial microbiota and childhood growth[J]. Front Pediatr, 2020, 8: 572538. DOI: 10.3389/fped.2020.572538 .
[10]
Willis KA, Purvis JH, Myers ED, et al. Fungi form interkingdom microbial communities in the primordial human gut that develop with gestational age[J]. FASEB J, 2019, 33(11): 12825-12837. DOI: 10.1096/fj.201901436RR.
[11]
Fauzan AH, Mejia JLC, Krych L, et al. Gut mycobiome dysbiosis is linked to hypertriglyceridemia among home dwelling elderly danes[J]. Cold Spring Harbor Laboratory, 2020. DOI: 10.1101/2020.04.16.044693.
[12]
Kuenzig ME, Fung SG, Marderfeld L, et al. Twenty-first century trends in the global epidemiology of pediatric-onset inflammatory bowel disease: systematic review[J]. Gastroenterology, 2022, 162(4): 1147-1159.e4. DOI: 10.1053/j.gastro.2021.12.282.
[13]
Park J, Cheon JH. Incidence and prevalence of inflammatory bowel disease across Asia[J]. Yonsei Med J, 2021, 62(2): 99-108. DOI: 10.3349/ymj.2021.62.2.99.
[14]
Wang XQ, Zhang Y, Xu CD, et al. Inflammatory bowel disease in Chinese children: a multicenter analysis over a decade from Shanghai[J]. Inflamm Bowel Dis, 2013, 19(2): 423-428. DOI: 10.1097/MIB.0b013e318286f9f2.
[15]
Iliev ID, Funari VA, Taylor KD, et al. Interactions between commensal fungi and the C-type lectin receptor Dectin-1 influence colitis[J]. Science, 2012, 336(6086): 1314-1317. DOI: 10.1126/science.1221789.
[16]
Wang T, Pan D, Zhou Z, et al. Dectin-3 deficiency promotes colitis development due to impaired antifungal innate immune responses in the gut[J]. PLoS Pathog, 2016, 12(6): e1005662. DOI: 10.1371/journal.ppat.1005662.
[17]
Doron I, Leonardi I, Li XV, et al. Human gut mycobiota tune immunity via CARD9-dependent induction of anti-fungal IgG antibodies[J]. Cell, 2021, 184(4): 1017-1031.e14. DOI: 10.1016/j.cell.2021.01.016.
[18]
Mogilnicka I, Ufnal M. Gut mycobiota and fungal metabolites in human homeostasis[J]. Curr Drug Targets, 2019, 20(2): 232-240. DOI: 10.2174/1389450119666180724125020.
[19]
魏文娟，缪佳蓉，缪应雷. 炎症性肠病患者的肠道真菌组成及其影响因素[J]. 国际消化病杂志，2022, 42(3): 146-149. DOI: 10.3969/j.issn.1673-534X.2022.03.002.
[20]
Lam S, Zuo T, Ho M, et al. Review article: fungal alterations in inflammatory bowel diseases[J]. Aliment Pharmacol Ther, 2019, 50(11-12): 1159-1171. DOI: 10.1111/apt.15523.
[21]
Qiu X, Zhao X, Cui X, et al. Characterization of fungal and bacterial dysbiosis in young adult Chinese patients with Crohn′s disease[J]. Therap Adv Gastroenterol, 2020, 13: 1756284820971202. DOI: 10.1177/1756284820971202.
[22]
Yadav A, Yadav R, Sharma V, et al. A comprehensive guide to assess gut mycobiome and its role in pathogenesis and treatment of inflammatory bowel disease[J]. Indian J Gastroenterol, 2024, 43(1): 112-128. DOI: 10.1007/s12664-023-01510-0.
[23]
Liu S, Zhao W, Lan P, et al. The microbiome in inflammatory bowel diseases: from pathogenesis to therapy[J]. Protein Cell, 2021, 12(5): 331-345. DOI: 10.1007/s13238-020-00745-3.
[24]
Li XV, Leonardi I, Putzel GG, et al. Immune regulation by fungal strain diversity in inflammatory bowel disease[J]. Nature, 2022, 603(7902): 672-678. DOI: 10.1038/s41586-022-04502-w.
[25]
Limon JJ, Tang J, Li D, et al. Malassezia is associated with Crohn′s disease and exacerbates colitis in mouse models[J]. Cell Host Microbe, 2019, 25(3): 377-388.e6. DOI: 10.1016/j.chom.2019.01.007.
[26]
Zeng X, Li X, Yue Y, et al. Ameliorative effect of Saccharomyces cerevisiae JKSP39 on Fusobacterium nucleatum and dextran sulfate sodium-induced colitis mouse model[J]. J Agric Food Chem, 2022, 70(44): 14179-14192. DOI: 10.1021/acs.jafc.2c05338.
[27]
Rodrigues M, Bueno C, Lomazi EA, et al. Classical serological markers in pediatric inflammatory bowel disease in Brazil[J]. Arq Gastroenterol, 2021, 58(4): 495-503. DOI: 10.1590/S0004-2803.202100000-89.
[28]
Bourgonje AR, Vogl T, Segal E, et al. Antibody signatures in inflammatory bowel disease: current developments and future applications[J]. Trends Mol Med, 2022, 28(8): 693-705. DOI: 10.1016/j.molmed.2022.05.004 .
[29]
Kim JM, Choi YM, Jung SA, et al. Diagnostic utility, disease activity, and disease phenotype correlation of serum ASCA, pANCA, and PR3-ANCA in pediatric inflammatory bowel disease[J]. J Pediatr (Rio J), 2024, 100(2): 204-211. DOI: 10.1016/j.jped.2023.10.005 .
[30]
Duarte-Silva M, Afonso PC, de Souza PR, et al. Reappraisal of antibodies against Saccharomyces cerevisiae (ASCA) as persistent biomarkers in quiescent Crohn′s disease[J]. Autoimmunity, 2019, 52(1): 37-47. DOI: 10.1080/08916934.2019.1588889 .
[31]
Gao X, Zhang Y. Serological markers facilitate the diagnosis of Crohn′s disease[J]. Postgrad Med, 2021, 133(3): 286-290. DOI: 10.1080/00325481.2021.1873649 .
[32]
Ricciuto A, Aardoom M, Orlanski-Meyer E, et al. Predicting outcomes in pediatric Crohn′s disease for management optimization: systematic review and consensus statements from the pediatric inflammatory bowel disease-ahead program[J]. Gastroenterology, 2021, 160(1): 403-436.e26. DOI: 10.1053/j.gastro.2020.07.065.
[33]
中华医学会消化病学分会炎症性肠病学组，中国炎症性肠病诊疗质量控制评估中心. 中国克罗恩病诊治指南(2023年·广州)[J]. 中华炎性肠病杂志(中英文), 2024, 8(1): 2-32. DOI: 10.3760/cma.j.cn101480-20240108-00006.
[34]
中华医学会儿科学分会消化学组，中华医学会儿科学分会临床营养学组. 儿童炎症性肠病诊断和治疗专家共识[J]. 中华儿科杂志，2019, 57(7): 501-507. DOI: 10.3760/cma.j.issn.057810.2019.07.002.
[35]
Huang X, Hu M, Sun T, et al. Multi-kingdom gut microbiota analyses define bacterial-fungal interplay and microbial markers of pan-cancer immunotherapy across cohorts[J]. Cell Host Microbe, 2023, 31(11): 1930-1943.e4. DOI: 10.1016/j.chom.2023.10.005.
[36]
高洁，吴开春. 免疫调节治疗在炎症性肠病治疗中的应用现状以及面临的困境[J]. 中华医学信息导报，2021, 36(19): 21. DOI: 10.3760/cma.j.issn.1000-8039.2021.19.129.
[37]
Atreya R, Neurath MF. Biomarkers for Personalizing IBD therapy: the quest continues[J]. Clin Gastroenterol Hepatol, 2024: S1542-3565(24)00104-6. DOI: 10.1016/j.cgh.2024.01.026
[38]
Jain U, Ver Heul1 AM, Xiong SS, et al. Debaryomyces is enriched in Crohn′s disease intestinal tissue and impairs healing in mice[J]. Science, 2021, 371(6534): 1154-1159. DOI: 10.1126/science.abd0919.
[39]
Danne C, Rolhion N, Sokol H. Recipient factors in faecal microbiota transplantation: one stool does not fit all[J]. Nat Rev Gastroenterol Hepatol, 2021, 18(7): 503-513. DOI: 10.1038/s41575-021-00441-5.
[40]
Costello SP, Hughes PA, Waters O, et al. Effect of fecal microbiota transplantation on 8-week remission in patients with ulcerative colitis: a randomized clinical trial[J]. JAMA, 2019, 321(2): 156-164. DOI: 10.1001/jama.2018.20046.
[41]
Pai N, Popov J, Hill L, et al. Results of the first pilot randomized controlled trial of fecal microbiota transplant in pediatric ulcerative colitis: lessons, limitations, and future prospects[J]. Gastroenterology, 2021, 161(2): 388-393.e3. DOI: 10.1053/j.gastro.2021.04.067.
[42]
中华医学会消化病学分会炎症性肠病学组儿科协作组，中华医学会儿科学分会临床营养学组. 儿童炎症性肠病诊疗中心质量控制标准专家共识[J]. 中华儿科杂志，2023, 61(2): 117-121. DOI: 10.3760/cma.j.cn112140-20220608-00525.
[43]
Allegretti JR, Kelly CR, Grinspan A, et al. Inflammatory bowel disease outcomes following fecal microbiota transplantation for recurrent C. difficile infection[J]. Inflamm Bowel Dis, 2021, 27(9): 1371-1378. DOI: 10.1093/ibd/izaa283.
[44]
Zuo T, Wong SH, Cheung CP, et al. Gut fungal dysbiosis correlates with reduced efficacy of fecal microbiota transplantation in Clostridium difficile infection[J]. Nat Commun, 2018, 9(1): 3663. DOI: 10.1038/s41467-018-06103-6.
[45]
Tian H, Zhang S, Qin H, et al. Long-term safety of faecal microbiota transplantation for gastrointestinal diseases in China[J]. Lancet Gastroenterol Hepatol, 2022, 7(8): 702-703. DOI: 10.1016/S2468-1253(22)00170-4.
[46]
Pais P, Almeida V, Ylmaz M, et al. Saccharomyces boulardii: what makes it tick as successful probiotic？[J]. J Fungi: Open Access Mycol J, 2020, 6(2): 78. DOI: 10.3390/jof6020078.
[47]
Li B, Zhang H, Shi L, et al. Saccharomyces boulardii alleviates DSS-induced intestinal barrier dysfunction and inflammation in humanized mice[J]. Food Funct, 2022, 13(1): 102-112. DOI: 10.1039/d1fo02752b.
[48]
史刚刚，韩梅，郝敬鹏，等. 布拉酵母菌的作用机制及其在溃疡性结肠炎中应用的研究进展[J]. 国际生物医学工程杂志，2021, 44(2): 163-163. DOI: 10.3760/cma.j.cn121382-20200917-00213 .
[49]
Huo X, Li D, Wu F, et al. Cultivated human intestinal fungus Candida metapsilosis M2006B attenuates colitis by secreting acyclic sesquiterpenoids as FXR agonists[J]. Gut, 2022, 71(11): 2205-2217. DOI: 10.1136/gutjnl-2021-325413.
[50]
Scott BM, Gutiérrez-Vázquez C, Sanmarco LM, et al. Self-tunable engineered yeast probiotics for the treatment of inflammatory bowel disease[J]. Nat Med, 2021, 27(7): 1212-1222. DOI: 10.1038/s41591-021-01390-x.
[51]
Chiaro TR, Soto R, Zac Stephens W, et al. A member of the gut mycobiota modulates host purine metabolism exacerbating colitis in mice[J]. Sci Transl Med, 2017, 9(380): eaaf9044. DOI: 10.1126/scitranslmed.aaf9044.
[1] Haolun Li, Jiaqi Yang, Yu Li. Current research status of clinical effect of hydromorphone hydrochloride in pediatric postoperative analgesia[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(02): 166-171.
[2] Fang Liu, Chunyuan Huang, Fenglin Wang, Yimei Ma, Tao Tang, Wenjia Hou, Lei Liu. Summary of the best evidence on non-pharmacological management for procedural pain of burn wounds in children[J]. Chinese Journal of Injury Repair and Wound Healing(Electronic Edition), 2024, 19(02): 159-164.
[3] Weijun Zheng, Yifan Fang, Dianming Wu, Xiang Wang, Fei Chen, Mingkun Liu. Diagnosis and treatment of congenital malrotation of the intestine: a summary of 10 years of experience in a single center[J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2024, 18(03): 338-341.
[4] Pan Li, Dengfei Wei, Kekun Qiao, Xionggang Li. Comparison of ultrasound-guided sacral canal block with ilioinguinal and iliohypogastric nerve block for pediatric laparoscopic high ligation of hernial sac[J]. Chinese Journal of Hernia and Abdominal Wall Surgery(Electronic Edition), 2024, 18(03): 326-330.
[5] Zilin Cheng, Ming Dai, Jianhua Li, Liang Ma. Application of enhanced recovery after surgery concept in perioperative period of inguinal hernia[J]. Chinese Journal of Hernia and Abdominal Wall Surgery(Electronic Edition), 2024, 18(03): 331-335.
[6] Jianli Guo, Na Zhu, Fei Song, Guodong Chai. Application effect of sevoflurane inhalation combined with remifentanil anesthesia in laparoscopic hernia repair in children[J]. Chinese Journal of Hernia and Abdominal Wall Surgery(Electronic Edition), 2024, 18(02): 223-227.
[7] Zhizu Zhong, Boyuan Tao, Jixiao Zeng, Qiang Wu, Zhe Wang, Jiakang Yu, Fei Liu, Xiaogang Xu, Menglong Lan, Zijian Liang, Yanqiu Li, Fengjun Liu. Risk factors analysis of postoperative complications after laparoscopic radical surgery for pediatric choledochal cyst[J]. Chinese Journal of Laparoscopic Surgery(Electronic Edition), 2024, 17(02): 83-89.
[8] Jixiao Zeng, Zijian Liang. Single-port laparoscopic surgery in pediatric general surgery[J]. Chinese Journal of Laparoscopic Surgery(Electronic Edition), 2024, 17(02): 65-69.
[9] Zengmeng Wang, Chunhui Peng, Dongyang Wu, Kai Wang, Jun Yan, Xinjie Huang, Yajun Chen. Laparoscopic surgical experience of redo surgery for jejunohepatic anastomotic stricture/intrahepatic cholelithiasis after primary surgery in children with congenital choledochal cyst[J]. Chinese Journal of Laparoscopic Surgery(Electronic Edition), 2024, 17(02): 111-115.
[10] Zhikun Zhang, Zhongce Li, Yifei Zheng, Shiqin Qi. Application experience of single-site laparoscopic partial splenectomy in pediatric spleen diseases[J]. Chinese Journal of Laparoscopic Surgery(Electronic Edition), 2024, 17(02): 116-119.
[11] Fulati Xiapukaiti·, Tuxun Tuerhongjiang·, Hao Wen, Gang Yao. Timing, procedures and efficacy of liver transplantation in children with biliary atresia[J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2024, 13(01): 1-4.
[12] Yuli Liu, Yao Yao, Jinwen Xu. Analysis of influencing factors of renal insufficiency in children with Henoch-Schönlein purpura nephritis[J]. Chinese Journal of Kidney Disease Investigation(Electronic Edition), 2024, 13(02): 68-73.
[13] Jiuhong Wang, Li Ding, Li Liang. Diagnostic value and experience of abdominal color ultrasound combined with high-frequency color ultrasound in children with intussusception[J]. Chinese Journal of Digestion and Medical Imageology(Electronic Edition), 2024, 14(03): 226-228.
[14] Huanhuan Xuan, Fenglin Liu, Wei Li, Zipu Li, Baojun Jia, Jinju Wang, Yigang Man. Diagnostic features of Kawasaki disease shock syndrome complicated with reversible splenial lesion syndrome in children and literature review[J]. Chinese Journal of Diagnostics(Electronic Edition), 2024, 12(02): 95-100.
[15] Zhaoquan Liu, Fangfang Zhang, Honghao Song, Gang Wang, Mingyu Cui. Diagnostic features of intraperitoneal inflammatory myofibroblastic tumor in children and literature review[J]. Chinese Journal of Diagnostics(Electronic Edition), 2024, 12(02): 101-106.
Viewed
Full text


Abstract

Copyright © Chinese Medical Association, Chinese Medical Multimedia Press  京ICP备14006079号-1  网络出版服务许可证：(署)网出证(京)字第075号